Biosimilars Market Size Worth USD 95 Billion by 2030 at 23.90% CAGR – Report by Market Research Future (MRFR) Biosimilars Market Trends and Insights By Product (Recombinant Non-Glycosylated Proteins (Human Growth Hormone [RHGH], Granulocyte Colony-Stimulating Factor [Filgrastim], Insulin and Interferons), Recombinant Glycosylated Proteins (Erythropoietin [EPO], Monoclonal Antibodies [MABS] and Fol